Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 1;104(6):623-8.
doi: 10.1002/jso.21991. Epub 2011 Jun 21.

Minimally invasive esophagectomy for esophageal cancer: comparative analysis of open and hand-assisted laparoscopic abdominal lymphadenectomy with gastric conduit reconstruction

Affiliations

Minimally invasive esophagectomy for esophageal cancer: comparative analysis of open and hand-assisted laparoscopic abdominal lymphadenectomy with gastric conduit reconstruction

Makoto Yamasaki et al. J Surg Oncol. .

Abstract

Background and objectives: Esophagectomy for esophageal cancer is an invasive procedure. Minimally invasive approaches such as hand-assisted laparoscopic surgery (HALS) might reduce surgical stress and improve postoperative course.

Methods: We retrospectively analyzed 216 consecutive patients who underwent esophagectomy for esophageal cancer through either HALS (109 patients) or open laparotomy (107 patients), through an abdominal approach. The peri- and postoperative outcomes were compared between the two groups.

Results: No significant difference was observed in physical and tumor status between the two groups. The mean operating time (HALS: 452 ± 65, Open: 456 ± 69 min) and mean number of resected lymph nodes (HALS: 19.3 ± 7.1, Open: 20.8 ± 8.3) were similar, while total blood loss was lower in HALS (HALS: 695 ± 369, Open: 1,101 ± 540 ml; P = 0.0001). The postoperative course showed marginally lower incidences of pulmonary (HALS: 6.4%, Open: 14.0%; P = 0.062) and overall complications (HALS: 23.9%, Open: 35.5%; P = 0.11), lower C-reactive protein level at postoperative days 1, 3, and 7, and shorter duration of systemic inflammatory response syndrome (HALS: 2.3 days, Open: 3.5 days; P = 0.0002) in HALS than in OPEN. The disease-free survival rates at 2 years were 65% in HALS and 53% in Open.

Conclusions: The findings suggest that HALS is feasible and useful for patients with esophageal cancer.

PubMed Disclaimer